SCHEMBL566413

SCHEMBL566413

COCc1ccc(C(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.62
POLB P06746 1/20 0.62
RAB9A P51151 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
ALDH1A1 P00352 2/20 0.59
RXRA P19793 8/20 0.59
RXRB P28702 7/20 0.58
RXRG P48443 1/20 0.54
PLA2G4B P0C869 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
NR4A2 P43354 4/20 0.53
NR4A1 P22736 1/20 0.53
NR4A3 Q92570 1/20 0.53
TP53 P04637 1/20 0.52
TSHR P16473 1/20 0.52
HPGD P15428 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14715123 0.94 NPC1 (0.57) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL29118546 0.91 NPC1 (0.54) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
Benzoic Acid SCHEMBL29002939 0.88 NR4A2 (0.59) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL10709493 0.84 CES2 (0.52) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL7041079 0.84 ATM (0.54) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
Benzoic Acid SCHEMBL29002950 0.84 RAB9A (0.69) NPC1POLBRAB9ASMN1; SMN2RXRA
SCHEMBL1104605 0.83 KMT2A (0.61) RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL30438420 0.82 RXRA (0.51) NPC1POLBRAB9ASMN1; SMN2RXRA
SCHEMBL9439348 0.82 ALDH1A1 (0.69) NPC1POLBRAB9ASMN1; SMN2ALDH1A1
SCHEMBL11472200 0.82 ATM (0.66) NPC1RAB9ASMN1; SMN2ALDH1A1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279206-A Flavor composition 弗门尼舍有限公司 2022-11-01 CN claimed
CN-110922810-B Conductive polymer 3D printing ink and preparation method thereof 江西科技师范大学 2022-04-29 CN claimed
CN-110845512-B Total synthesis method of triterpenoid natural product (+) -Arisugacins F/G 中国海洋大学 2020-09-18 CN claimed
CN-110845512-A Total synthesis method of triterpenoid natural product (+) -Arisugacins F/G 中国海洋大学 2020-02-28 CN claimed
EP-0358574-B1 PROCESS FOR THE PREPARATION OF ADAMANTANE-1 DERIVATIVES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA (FR) 1993-02-17 EP claimed
US-20240329525-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-10-03 US disclosed
US-20240210827-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-06-27 US disclosed
CN-113666826-B Aryl or heteroaryl methoxylation reaction method 五邑大学 2024-03-26 CN disclosed
CN-117736097-A Method for preparing carboxylic ester compound by oxidative cleavage of carbon-carbon double bond of olefin compound 中国科学院大连化学物理研究所 2024-03-22 CN disclosed
US-20230373932-A1 DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2023-11-23 US disclosed
US-11697636-B2 Substituted benzamides HOFFMANN-LA ROCHE INC. (US) 2023-07-11 US disclosed
CN-113820920-B Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device 旭化成株式会社 2023-07-04 CN disclosed
US-20030181496-A1 Pyrrole derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2003-09-25 US disclosed
EP-1310485-A1 PYRROLE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2003-05-14 EP disclosed
CN-1323309-A Phenyl xanthine derivatives GLAXO GROUP LTD (GB) 2001-11-21 CN disclosed
US-5783587-A PSYCHOLOGICAL AND BRAIN DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-21 US disclosed
EP-0839134-A1 BENZOYL PIPERIDINES/PYRROLIDINES FOR ENHANCING SYNAPTIC RESPONSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-05-06 EP disclosed
US-5650409-A FOR IMPROVING MEMORY, OR TREATING DEPRESSION, ALCOHOLISM OR SCHIZOPHRENIA CORTEX PHARMACEUTICALS, INC. (US) 1997-07-22 US disclosed
WO-1996038414-A1 BENZOYL PIPERIDINES/PYRROLIDINES FOR ENHANCING SYNAPTIC RESPONSE CORTEX PHARMACEUTICALS, INC. (US) 1996-12-05 WO disclosed
US-4640906-A ORGANOALUMINUM COMPOUND, PIPERIDINE DERIVATIVE AND SOLID FROM DIALKOXYMAGNESIUM COMPOUND, AROMATIC DIESTER AND HALOGENATED HYDROCARBON TOHO TITANIUM CO., LTD. (JP) 1987-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181496-A1 Pyrrole derivatives NCOA1, PKD1, NR3C2 NPC1 1814/4885POLB 3063/4885RAB9A 2993/4885
US-20230373932-A1 DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF REN, PKD2, ALPI NPC1 380/4885POLB 4485/4885RAB9A 1525/4885
US-11697636-B2 Substituted benzamides TAAR1, TAAR5, NPY1R NPC1 937/4885POLB 2718/4885RAB9A 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.